Evidence map›Paper›PMID 30354871›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.

Viktoria Zoufal, Thomas Wanek, Markus Krohn, Severin Mairinger, Thomas Filip, Michael Sauberer, Johann Stanek, Thomas Pekar, Martin Bauer, Jens Pahnke and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. The blood-brain barrier: a help and a hindrance.Brain : a journal of neurology · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Performance and Sensitivity of [Molecular pharmaceutics · 2024
    Article
  6. Review
  7. [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  8. Review
  9. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a β-Amyloidosis Mouse Model withJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  14. Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Viktoria ZoufalCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Thomas WanekCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Markus KrohnDepartment of Neuro/Pathology, University of Oslo (UiO) and Oslo University Hospital (OUS), Oslo, Norway.
Severin MairingerCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Thomas FilipCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Michael SaubererCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Johann StanekCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Thomas PekarUniversity of Applied Sciences, Wiener Neustadt, Austria.
Martin BauerDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Jens PahnkeDepartment of Neuro/Pathology, University of Oslo (UiO) and Oslo University Hospital (OUS), Oslo, Norway.
Oliver LangerCenter for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.
Austrian Institute of Technology · ATOslo University Hospital · NOFachhochschule Wiener Neustadt · ATMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P-glycoprotein (P-gp, ABCB1) is an efflux transporter at the blood-brain barrier (BBB), which mediates clearance of beta-amyloid (Aβ) from brain into blood. We used (

Indexed as

Brain ChemistryAge FactorsAlzheimer DiseaseAmyloidosisAnimalsATP Binding Cassette Transporter, Subfamily B, Member 1Biological TransportBlood-Brain BarrierDisease Models, AnimalMicePositron-Emission TomographyQuinolinesATP Binding Cassette Transporter, Subfamily B, Member 1QuinolinestariquidarAlzheimer’s diseaseAPPPS1 micebeta-amyloidblood–brain barrierP-glycoprotein

Identifiers

PMID30354871
PMCPMC6928546
OpenAlexW2898105955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.